12-120978302-C-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBP6
The ENST00000433033.3(HNF1A-AS1):n.134+1312G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00027 in 152,076 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.00027 ( 0 hom., cov: 32)
Consequence
HNF1A-AS1
ENST00000433033.3 intron
ENST00000433033.3 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -2.42
Genes affected
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -3 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 12-120978302-C-T is Benign according to our data. Variant chr12-120978302-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 449034.We mark this variant Likely_benign, oryginal submissions are: {Uncertain_significance=1, Benign=1}.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000270 AC: 41AN: 152076Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
41
AN:
152076
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.000270 AC: 41AN: 152076Hom.: 0 Cov.: 32 AF XY: 0.000175 AC XY: 13AN XY: 74282
GnomAD4 genome
AF:
AC:
41
AN:
152076
Hom.:
Cov.:
32
AF XY:
AC XY:
13
AN XY:
74282
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Oct 30, 2017 | The c.-467 C>T variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. The variant is observed in 4/8716 (0.046%) alleles from individuals of African background in large population cohorts (Lek et al., 2016). This variant occurs at a position that is not conserved. Other regulatory variants, including nearby c.-462G>A, have been reported in the Human Gene Mutation Database in association with HNF1A-associated disorders (Stenson et al., 2014). In summary, based on the currently available information, it is unclear whether this variant is a pathogenic variant or a rare benign variant. - |
HNF1A-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Aug 05, 2024 | The HNF1A c.-467C>T variant is located in the 5' untranslated region. To our knowledge, this variant has not been reported in the literature. Of note, other pre-coding variants have been reported in patients with maturity onset diabetes of the young (MODY) or type 2 diabetes (see for example at Colclough et al. 2013. PubMed ID: 23348805; Cox et al. 1999. PubMed ID: 10027593). This variant is reported in 0.046% of alleles in individuals of African descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Maturity onset diabetes mellitus in young Benign:1
Benign, criteria provided, single submitter | research | Clinical Genomics, Uppaluri K&H Personalized Medicine Clinic | - | Mutations in HNF1A gene can predispose to MODY3. It is associated with both micro and macrovascular complications of diabetes, especially cardiovascular complications. Associated with glucosuria. May respond well to sulfonylureas. However, more evidence is required to confer the association of this particular variant rs1039479235 with MODY3. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at